Neoadjuvant chemotherapy for pancreatic cancer and changes in the biliary microbiome

The use of neoadjuvant chemotherapy (NAC) for pancreatic ductal adenocarcinoma (PDAC) has increased in recent years. Limited data exists on the impact of NAC on biliary microbiome.

Source: American Journal of Surgery - October 4, 2020 Category: Surgery Authors: Syed Omair Nadeem, Mohammad Raheel Jajja, Daniel W. Maxwell, Stephanie M. Pouch, Juan M. Sarmiento Source Type: research